Retired Chief Executive Officer, CommonSpirit Health

• Kevin served as Chief Executive Officer Emeritus of CommonSpirit Health, prior to retiring in 2020 after overseeing the 2019 merger between Catholic Health Initiatives (CHI) and Dignity Health that formed one of the largest nonprofit health systems in the U.S.
• Previously served for nearly two decades as Chief Executive Officer of Catholic Health Initiatives (CHI), leading its significant growth and transformation.
• Held earlier leadership roles as Executive Director and Chief Executive Officer of Howard University Hospital and UAB Hospital in Birmingham.
• Kevin is a Life Fellow of the American College of Healthcare Executives, a Board member of Howard University, and Chair of the Board of the Georgia State University Foundation. Kevin currently serves on the Board of Directors of Medtronic plc. He previously served on the boards of Gilead Sciences, Inc., Rite Aid Corporation and Morehouse School of Medicine.
• Kevin earned a Bachelor of Science (B.S.) from Boston University Questrom School of Business and a Master of Healthcare Administration (M.H.A.) from Georgia State University.

Chief Executive Officer, MiniMed

• Que served as Executive Vice President and President of the Diabetes Operating Unit at Medtronic since May 2022, and as a member of the company's Executive Committee.
• Que is experienced in new product development and commercialization, having managed robust product portfolios, led end-to-end research and development, innovation, and directed business development initiatives that strengthened both organic and inorganic company growth.
• Que previously served as President and Chief Executive Officer of Honeywell Connected Enterprise and as Senior Vice President and Chief Commercial Officer at Honeywell, where she led strategy, marketing, sales, product innovation, and IoT solutions. 
• Que’s earlier roles included general management at TE Connectivity, senior strategy and M&A positions at Microsoft, and early career experience at McKinsey & Company. 
• Que currently serves as an independent director on the board of Lattice Semiconductor (NASDAQ: LSCC).
• Que earned a Bachelor of Science (B.S.) in Applied Mathematics and a Bachelor of Commerce (B.Com) in Finance from the University of New South Wales, Australia, and a Master of Business Administration (M.B.A.) from INSEAD in France.

Former Executive Vice President and Chief Financial Officer, Labcorp Holdings Inc.

• Glenn served as Executive Vice President and Chief Financial Officer of Labcorp from mid-2014 until December 2024 and continued as Special Advisor to the CEO through April 2025 to ensure a smooth transition.
• Over the course of his tenure, Glenn helped steer Labcorp through approximately 100 acquisitions, deploying about $11 billion into growth and delivering strong shareholder returns.
• Prior to joining Labcorp, Glenn served as Executive Vice President of Finance and Administration and Chief Financial Officer at The Timken Company, a leading global manufacturer of engineered bearings and power transmission products. Earlier in his career, he was President and Chief Operating Officer of United Dominion Industries, a global diversified industrial company, after holding several executive positions there, including Chief Financial Officer and President of its Test Instrumentation segment.
• Glenn currently serves on the Boards of Directors of Solventum Corporation, a global diversified healthcare company, and AMSURG, a nationally recognized leader in the strategic and operational management of surgery centers. He previously served on the public boards of Family Dollar Stores, Inc., Perspecta Inc., US Ecology, Inc., and Alpha Natural Resources, Inc.
• Glenn earned a Bachelor of Arts (B.A.) from Tulane University and a Master of Business Administration (M.B.A.) from Georgia State University.

Former President and Chief Executive Officer, Nevro Corp

• Keith served as President and Chief Executive Officer of Nevro from March 2019 to April 2023, then transitioned to Executive Chairman and later to Non-Executive Chairman of the Board.
• Keith is a four-time public company CEO and has served as a board member of nine public and eight private companies. As CEO or Director, he has led or participated in billions of dollars of shareholder value creation driven by organic enterprise growth.
• Keith brings more than 35 years of leadership in medical devices, with notable tenures at Thoratec Corporation (leading growth culminating in a $3.4B sale to St. Jude), Conceptus, Inc. (guided to eventual sale to Bayer), and as Managing Director at Texas Pacific Group.
• Keith currently serves as Vice Chairman of Alcon, Inc., Chairman of Outset Medical, Inc. and has held board roles at  Intuitive Surgical, Inc., Kyphon, Inc., Zeltiq, Inc., and several privately held medical device companies.
• Keith earned a Bachelor of Science in Life Sciences (B.S.) from The Ohio State University and a Master of Business Administration (M.B.A.) from Pepperdine University.

Senior Vice President, Head of Global Strategy, Medtronic

• Bob serves as the Senior Vice President and Head of Global Strategy at Medtronic, where he steers the company’s strategic direction with an emphasis on capital allocation and portfolio oversight.
• Bob joined Medtronic in November 2021 from Bank of America Merrill Lynch, where he was a Managing Director and Senior Equity Research Analyst covering the medical technology industry, including Medtronic.
• Bob holds more than 25 years of extensive MedTech experience and has been consistently recognized as a leading industry analyst.
• Bob previously served as a Managing Director at Lehman Brothers Holdings Inc., as well as a Vice President at Donaldson, Lufkin & Jenrette.
• Bob earned a Bachelor of Arts (B.A.) in Political Science from Trinity College (Hartford) and a Master of Business Administration (M.B.A.) from Columbia Business School. 

Senior Vice President, Chief Scientific and Medical Officer, Medtronic

• Laura serves as Senior Vice President and Chief Scientific and Medical Officer at Medtronic, where she leads the global scientific, medical, clinical research, and regulatory affairs teams and serves on the Executive Committee. 
• Laura joined Medtronic in September 2018 as Vice President of Global Clinical Research and Analytics. She served as executive sponsor of the company's efforts to unify Medtronic's global clinical research leaders across all product areas and led the company's clinical trial response and mitigation plans for COVID-19. She has also been responsible for advancing novel analytic and data science solutions to generate global clinical evidence for Medtronic products.
• Laura is an interventional cardiologist who practiced at Brigham and Women’s Hospital for 15 years. As an internationally recognized investigator and Professor of Medicine at Harvard Medical School, she helped shape the clinical evaluation of new medical technologies, providing greater insight into the interactions among medical devices, clinical practice, and concurrent pharmaceutical therapy.
• Laura earned an Artium Baccalaureus (A.B.), magna cum laude, from Harvard College; a Doctor of Medicine (M.D.), magna cum laude, from Harvard Medical School; and a Master of Science (M.Sc.) in Clinical Epidemiology from the Harvard School of Public Health. She completed her residency in internal medicine and fellowships in cardiovascular disease and interventional cardiology at Brigham and Women’s Hospital.

Executive Vice President and President, Neuroscience Portfolio, Medtronic

• Brett serves as Executive Vice President and President of Medtronic’s Neuroscience Portfolio, overseeing five major operating units—Neuromodulation, Cranial & Spinal Technologies, Neurovascular, Pelvic Health, and Ear, Nose & Throat—that collectively generate more than $8 billion in annual revenue and employ approximately 15,000 people globally.
• Brett also serves as Executive Sponsor of the Medtronic African Descent Network—an internal national resource group that focuses on recruitment, engagement, retention, and development for employees of African descent.
• Prior to Medtronic's acquisition of Covidien, Brett served as President, Neurovascular and International, at Covidien, where he managed all commercial activities and business functions, resulting in a doubling of revenue during his tenure. He also served as Senior Vice President and President, Neurovascular, and as Senior Vice President and President, International, at ev3, Inc. Before the ev3 merger with Micro Therapeutics, Brett held the role of Micro Therapeutic Vice President of Marketing for the Neurovascular and Peripheral Vascular divisions.
• Brett earned a Bachelor of Science (B.S.) in Comprehensive Business Administration, with a concentration in Marketing, from the University of Nebraska at Kearney.

Senior Vice President and Chief Human Resources Officer, Medtronic

• Matt serves as Senior Vice President and Chief Human Resources Officer at Medtronic, and as a member of the company's Executive Committee and leading talent, culture, and organizational strategies that support a global workforce of more than 95,000 employees.
• Matt was appointed Chief Human Resources Officer in July 2023, following nine years with Medtronic in various HR leadership roles. Most recently, he served as Vice President of Human Resources for Global Operations and Supply Chain, where he was responsible for HR strategies supporting nearly half of the company's global workforce. Earlier in his tenure, he held business partner roles in the Restorative Therapies Group, Coronary, Structural Heart, and Diabetes businesses, and also worked in the Global Talent and Leadership Development Center of Expertise.
• Before joining Medtronic, Matt held HR leadership roles at Best Buy and Bank of America, bringing more than 20 years of cross-industry expertise.
• Matt earned a Bachelor of Science (B.S.) in Psychology from Saint Francis University and a Ph.D. in Industrial and Organizational Psychology from Colorado State University.

Former Executive Vice President and Chief Financial Officer, Optum

• Tim is the retired Executive Vice President & Chief Financial Officer of Optum, where he steered major divisions including Optum Financial, Supply Chain, and OptumRx after nearly 20 years with UnitedHealth Group.
• Tim held leadership roles across Optum’s spectrum of operations, product, business development, and strategic relationships, and he also served on the board of Optum360.
• After leaving Optum, Tim was tapped as advisory board chair at MOBE and joined BrightSpring’s Board of Directors in April 2024.
• Tim has served on the boards of two public companies: Precision Castparts Corp. (sold to Berkshire Hathaway for $37B) and Aerojet Rocketdyne. He served on both companies' Finance and Audit Committees and is recognized as an SEC financial expert. He is also actively engaged in supporting the growth of several private companies.
• Tim earned a Bachelor of Arts (B.A.) in Economics from the University of Chicago and a Master of Business Administration (M.B.A.) from Harvard University Graduate School of Business.